AOK Sachsen - Anhalt
Germany · 288 open tenders · 199 documented awards
Current tenders
Framework Agreement for the Supply of Consumables and Accessories as well as Service Provision for MFPs
Deadline 16 Oct ·
Prevention Project "Active After-School Care"
Deadline 16 Oct ·
Prevention Project "Little Break Kindergarten"
BELOW THRESHOLDDeadline 16 Oct ·
Prevention Project "Active After-School Care"
Deadline 16 Oct ·
Framework Agreement for the Supply of Consumables and Accessories as well as Service for MFPs
Deadline 16 Oct ·
Prevention Project "Active Kindergarten"
BELOW THRESHOLDDeadline 16 Oct ·
Prevention project "Little break at the after-school club"
BELOW THRESHOLDDeadline 16 Oct ·
Prevention Project "School Backpack Check"
BELOW THRESHOLDDeadline 16 Oct ·
Medicinal product with the active substance Bimekizumab (ATC: L04AC21)
Deadline 30 Oct ·
Medicinal product with the active ingredient combination formoterol and beclomethasone (ATC: R03AK08 - in the strength 200/6 micrograms)
Deadline 30 Oct ·
Medicinal product with the active ingredient rituximab - in the pharmaceutical form infusion solution concentrate (ATC: L01FA01)
Deadline 30 Oct ·
Medicinal products with the active ingredient combination brimonidine and timolol (ATC: S01ED67)
Deadline 30 Oct ·
Medicines containing the active substance sevelamer hydrochloride (ATC: V03AE02)
Deadline 30 Oct ·
Medicinal product with the active ingredient combination brinzolamide and timolol (ATC: S01ED67)
Deadline 31 Oct ·
Medicinal product with the active substance Rituximab - in the pharmaceutical form infusion solution concentrate (ATC: L01FA01)
Deadline 31 Oct ·
Medicinal product with the active ingredient combination Formoterol and Beclometasone (ATC: R03AK08 - in the strength 200/6 micrograms)
Deadline 31 Oct ·
Medicine with the active substance Sevelamer hydrochloride (ATC: V03AE02)
Deadline 31 Oct ·
Medicinal product with the active substance Bimekizumab (ATC: L04AC21)
Deadline 31 Oct ·
Medicinal products with the active substance epinephrine (ATC: C01CA24)
Deadline 29 Nov ·
Medicinal product with the active substance Secukinumab (ATC: L04AC10)
Deadline 29 Nov ·
Medicinal products with the active substance pyridostigmine (ATC: N07AA02)
Deadline 29 Nov ·
Medicinal products containing the active substance mesalazine (ATC: A07EC02)
Deadline 29 Nov ·
Medicinal products with the active substance leuprorelin (ATC: L02AE02)
Deadline 29 Nov ·
Medicinal products with the active substance filgrastim (ATC: L03AA02)
Deadline 30 Nov ·
Medicinal products containing the active substance budesonide (ATC: A07EA06)
Deadline 30 Nov ·
Medicinal products with the active substance epinephrine (ATC: C01CA24)
Deadline 30 Nov ·
Medicinal products containing the active substance Pegfilgrastim (ATC: L03AA13)
Deadline 30 Nov ·
Medicinal products with the active substance Leuprorelin (ATC: L02AE02)
Deadline 30 Nov ·
Medicinal products containing the active substance mesalazine (ATC: A07EC02)
Deadline 30 Nov ·
Medicinal products with the active substance Secukinumab (ATC: L04AC10)
Deadline 30 Nov ·
Purchasing rhythm
Awards per year — who knows the rhythm prepares before the notice appears.
201821
201947
202069
202162
202253
2023157
2024323
2025389
2026226
Clement What the numbers say about this buyer
- The median procedure drew just one bid (99 procedures with a bid count); 60% ended with a single bidder. Country: median 3.1 bids.n = 99
- 49% of this buyer's awards went to companies that had already won here before (103 awards since 2018, spread over 53 companies). 51% went to new names.n = 103 awards since 2018
- Across 119 procedures with structured selection criteria, this buyer most often required: Trade register enrolment (118 of 119), Quality management (2 of 119), References: services (2 of 119), Professional liability insurance (2 of 119).n = 119
- Not one of the 103 awards with a known winner country has gone to a foreign company so far. National average: 1%.n = 103
- From notice to award takes a median 75 days here (17 procedures). Country: 91 days.n = 17
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Expected next awards
From the rhythm of past awards per sector — an expectation, not an announcement. Hit rate so far: 26% of 11,200 closed expectation windows produced a notice.
- Oct 2026IT services
about every 9 months · 23 awards · last Dec 2025 to in4MD Service GmbH - Jan 2027Medical equipment & pharma
about every 4 months · 36 awards · last Sept 2026 to Novo Nordisk Pharma GmbH - Apr 2027Petroleum & fuels
about every 20 months · 11 awards · last Aug 2025 to Städtische Werke Magdeburg GmbH & Co. KG
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Novartis Pharma GmbH · Nürnberg | 7 | 2013–2026 |
| PIK AG | 5 | 2025 |
| Bayer Vital GmbH · Leverkusen | 5 | 2014–2026 |
| GlaxoSmithKline GmbH & Co. KG · München | 5 | 2012–2026 |
| Pfizer Pharma GmbH · Berlin | 5 | 2023–2026 |
| Swedish Orphan Biovitrum GmbH · Langen | 5 | 2020–2026 |
| RpDoc Solutions GmbH · Saarbrücken | 4 | 2026 |
| Takeda GmbH · Konstanz | 4 | 2021–2026 |
| CSL Behring GmbH · Marburg/Lahn | 4 | 2020–2026 |
| Städtische Werke Magdeburg GmbH & Co. KG | 4 | 2025 |
From 18.0M documented awards · regular winners know this buyer's requirements — that is your competition.